Mesimeri kai Kati hosted the Deputy Director of Pharmaceutical Services, Elena Panagiotopoulou, who spoke about the possibility of changing the vaccine after the first dose, while referring to the third dose scenario.
He initially said that those vaccinated with the first dose of the AstraZeneca vaccine would receive a message that would specify the exact day and time they would be vaccinated with the second dose of the vaccine. He went on to say that if citizens have any questions they can contact us in 1474. "There are citizens who received the relevant message and their appointment was set."
At the same time, he explained that the physical disease does not offer enough antibodies that the vaccine does. "There are also mutations, with vaccines protecting the body."
He added that in the first dose of the vaccine there are mild symptoms such as chills, numbness and fever, while he stressed that one body may have more symptoms than another.
Ms. Panagiotopoulou pointed out that the second dose of the vaccine is not made by choosing vaccines. "It is in line with the data before us and so far we do not have such data for a vaccine change." He added that in some countries the tests started without any results.
He went on to say that if in the first dose of the vaccine there was no side effect of thrombosis, then it is even rarer to occur in the second dose. "Those who have experienced side effects from the vaccine can contact the website of the Pharmaceutical Services."
Regarding the third dose of the vaccine, he explained that there is still no data on how it will be. "They can be produced to protect against new strains of the coronavirus."
Finally, he said that those who have been vaccinated and are feeling well can continue their activities. "If they feel weak, it would be good to limit themselves for one day."
Watch the video:
Source: Sigmalive